HADHA

Chr 2

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha

Also known as: ECHA, GBP, LCEH, LCHAD, MLCL AT, MTPA, TP-ALPHA

This gene encodes the alpha subunit of the mitochondrial trifunctional protein, which catalyzes the last three steps of mitochondrial beta-oxidation of long chain fatty acids. The mitochondrial membrane-bound heterocomplex is composed of four alpha and four beta subunits, with the alpha subunit catalyzing the 3-hydroxyacyl-CoA dehydrogenase and enoyl-CoA hydratase activities. Mutations in this gene result in trifunctional protein deficiency or LCHAD deficiency. The genes of the alpha and beta subunits of the mitochondrial trifunctional protein are located adjacent to each other in the human genome in a head-to-head orientation. [provided by RefSeq, Jul 2008]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.62
Clinical SummaryHADHA
🧬
Gene-Disease Validity (ClinGen)
long chain 3-hydroxyacyl-CoA dehydrogenase deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
251 unique Pathogenic / Likely Pathogenic· 288 VUS of 1213 total submissions
📖
GeneReview available — HADHA
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.62LOEUF
pLI 0.000
Z-score 3.43
OE 0.41 (0.280.62)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.82Z-score
OE missense 0.88 (0.810.97)
355 obs / 401.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.41 (0.280.62)
00.351.4
Missense OE?0.88 (0.810.97)
00.61.4
Synonymous OE?1.06
01.21.6
LoF obs/exp: 16 / 39.1Missense obs/exp: 355 / 401.3Syn Z: -0.58
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveHADHA-related long chain 3-hydroxyacyl-CoA dehydrogenase deficiencyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7325th %ile
GOF
0.5758th %ile
LOF
0.3067th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

1213 submitted variants in ClinVar

Classification Summary

Pathogenic91
Likely Pathogenic160
VUS288
Likely Benign561
Benign52
Conflicting40
91
Pathogenic
160
Likely Pathogenic
288
VUS
561
Likely Benign
52
Benign
40
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
78
1
12
0
91
Likely Pathogenic
136
20
4
0
160
VUS
4
232
41
11
288
Likely Benign
0
6
262
293
561
Benign
0
2
49
1
52
Conflicting
40
Total2182613683051,192

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

16 pathogenic / likely-pathogenic (of 25) ClinVar copy-number / structural variants overlap HADHA — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

HADHA · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →